Nikolaus Heveker

The presence of the TAR RNA structure alters the programmed -1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation

Johanie Charbonneau, Karine Gendron, Gerardo Ferbeyre, 2007, Nucleic acids research.

Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay

Gabriella Scarlatti, V. Trouplin, N. Heveker, 2001, Journal of Virology.

Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways

N. Heveker, B. Volkman, S. Gravel, 2011, Proceedings of the National Academy of Sciences.

Identification of Residues of CXCR4 Critical for Human Immunodeficiency Virus Coreceptor and Chemokine Receptor Activities*

N. Heveker, M. Alizon, A. Brelot, 2000, The Journal of Biological Chemistry.

Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.

Oliver Hartley, Jill Wilken, Robin Offord, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Biased antagonism of CXCR4 avoids antagonist tolerance

Brian F. Volkman, Nadya I. Tarasova, N. Heveker, 2018, Science Signaling.

Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4

Michael M. Mysinger, Dahlia R. Weiss, Brian K Shoichet, 2012, Proceedings of the National Academy of Sciences.

Mode of binding of the cyclic agonist peptide TC14012 to CXCR7: identification of receptor and compound determinants.

Shinya Oishi, Pierre Lavigne, Nikolaus Heveker, 2015, Biochemistry.

Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers*

Michel Bouvier, Yann Percherancier, Hirokazu Tamamura, 2005, Journal of Biological Chemistry.